GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » EKIMAS Corp (OTCPK:ASNB) » Definitions » 5-Day RSI

EKIMAS (EKIMAS) 5-Day RSI : 34.88 (As of May. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is EKIMAS 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-05-06), EKIMAS's 5-Day RSI is 34.88.

The industry rank for EKIMAS's 5-Day RSI or its related term are showing as below:

ASNB's 5-Day RSI is not ranked
in the Diversified Financial Services industry.
Industry Median: 57.765 vs ASNB: 34.88

Competitive Comparison of EKIMAS's 5-Day RSI

For the Shell Companies subindustry, EKIMAS's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKIMAS's 5-Day RSI Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, EKIMAS's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where EKIMAS's 5-Day RSI falls into.



EKIMAS  (OTCPK:ASNB) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKIMAS  (OTCPK:ASNB) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


EKIMAS 5-Day RSI Related Terms

Thank you for viewing the detailed overview of EKIMAS's 5-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


EKIMAS (EKIMAS) Business Description

Traded in Other Exchanges
N/A
Address
3651 Lindell Road, Suite D565, Las Vegas, NV, USA, 89103
EKIMAS Corp is a shell company.
Executives
Partners Aps Gk 10 percent owner MESTERLODDEN 3B, GENTOFTE G7 2820
Henrik Oerbekker 10 percent owner 94, RUE DES AUBEPINES, L-1145, LUXEMBOURG N4 2449
Henrik Rouf 10 percent owner 468 N. CAMDEN DR., SUITE 350, BEVERLY HILLS CA 90210
Khristine L Carroll officer: EVP Commercial Operations 229 ANDOVER STREET, WILMINGTON MA 01887
Michael F Adams director, officer: Chief Executive Officer 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
David Crispino Volpe officer: Chief Financial Officer 235 STONEBRIDGE DRIVE, NASHUA NH 03063
Michael L Barretti director 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
Oneill William J Jr director 4000 HOLLYWOOD BLVD STE 650N, HOLLYWOOD FL 33021
Mark R Tauscher director
Eric G Walters officer: Vice President and CFO C/O MFIC CORP, 30 OSSIPEE RD., NEWTON MA 02464
Andrew Martin Reed officer: VP of Science and Technology 12106 WEST 75TH LANE, ARVADA CO 80005
Philip Alan Beck other: General manager 1230 CREEKSIDE CROSSING, STILLWATER MN 55082
Jeremiah E Dorsey director P.O. BOX 910, QUECHEE VT 05059
Leslie M Taeger officer: CFO
Douglas E Whittaker officer: President Gish Biomedical